We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$55.7B
AUM Growth
+$1.33B
Cap. Flow
+$2.27B
Cap. Flow %
4.08%
Top 10 Hldgs %
19.71%
Holding
3,688
New
269
Increased
1,855
Reduced
1,236
Closed
227

Sector Composition

Rank Sector Weight
1 Technology 10.05%
2 Financials 9.3%
3 Healthcare 7.74%
4 Industrials 6.94%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXI icon
2526
iShares Global Industrials ETF
EXI
$1.5B
$525K ﹤0.01%
+5,748
New +$542K
EWM icon
2527
iShares MSCI Malaysia ETF
EWM
$333M
$524K ﹤0.01%
+14,497
New +$508K
SHLM
2528
DELISTED
Schulman (A.) Inc
SHLM
$524K ﹤0.01%
12,187
-12,120
-50% -$494K
BKE icon
2529
Buckle
BKE
$2.36B
$523K ﹤0.01%
+23,622
New +$496K
PBR icon
2530
Petrobras
PBR
$116B
$523K ﹤0.01%
36,956
-703
-2% -$9.25K
GAP
2531
The Gap Inc
GAP
$7.37B
$522K ﹤0.01%
16,737
-2,477
-13% -$81.1K
ASA
2532
ASA Gold and Precious Metals
ASA
$1.12B
$521K ﹤0.01%
49,987
+14,243
+40% +$156K
KE
2533
Kimball Electronics
KE
$617M
$521K ﹤0.01%
+32,246
New +$580K
PGEN icon
2534
Precigen
PGEN
$2.45B
$520K ﹤0.01%
33,917
-905
-3% -$12.9K
XBI icon
2535
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.5B
$520K ﹤0.01%
41,800
-12,400
-23% -$1.13M
ROG icon
2536
Rogers Corp
ROG
$2.48B
$519K ﹤0.01%
4,340
+119
+3% +$18.1K
NXR
2537
DELISTED
NUVEEN ELECT TAX-FREE INC 3
NXR
$517K ﹤0.01%
36,344
+2,302
+7% +$33.1K
CEO
2538
DELISTED
CNOOC Limited
CEO
$517K ﹤0.01%
3,493
-3,807
-52% -$572K
SMLV icon
2539
State Street SPDR US Small Cap Low Volatility Index ETF
SMLV
$259M
$516K ﹤0.01%
5,814
+511
+10% +$45.9K
SNLN
2540
DELISTED
Highland/iBoxx Senior Loan ETF
SNLN
$516K ﹤0.01%
28,175
+300
+1% +$5.49K
GLAD icon
2541
Gladstone Capital
GLAD
$442M
$514K ﹤0.01%
29,890
-31,701
-51% -$570K
CIT
2542
DELISTED
CIT Group Inc.
CIT
$513K ﹤0.01%
9,969
+1,882
+23% +$98.9K
NI icon
2543
NiSource
NI
$20.1B
$509K ﹤0.01%
21,276
-56,226
-73% -$1.33M
KGC icon
2544
Kinross Gold
KGC
$32.9B
$507K ﹤0.01%
128,301
+30,746
+32% +$123K
BYM
2545
DELISTED
BlackRock Municipal Income Quality Trust
BYM
$505K ﹤0.01%
38,414
-630
-2% -$8.5K
JOE icon
2546
St. Joe Company
JOE
$3.93B
$504K ﹤0.01%
26,749
+762
+3% +$14.1K
CSD icon
2547
Invesco S&P Spin-Off ETF
CSD
$231M
$502K ﹤0.01%
9,401
-39
-0.4% -$2.11K
PAGS icon
2548
PagSeguro Digital
PAGS
$2.4B
$502K ﹤0.01%
+13,100
New +$421K
HPI
2549
John Hancock Preferred Income Fund
HPI
$436M
$501K ﹤0.01%
24,452
+131
+0.5% +$2.7K
SPXX icon
2550
Nuveen S&P 500 Dynamic Overwrite Fund
SPXX
$343M
$500K ﹤0.01%
29,198
+1,942
+7% +$34.4K

Similar funds

Raymond James & Associates's Q1 2018 Portfolio in Review

As of Q1 2018, Raymond James & Associates held 3,688 positions worth $55.7B, up 2.4% from $54.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raymond James & Associates deployed $2.27B of net new capital in Q1 2018, opening 269 new positions and adding to 1,855 existing holdings. Its largest new stake was Nutrien: 608,282 shares worth $28.7M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was AbbVie, an estimated $68.1M trimmed.

  • Raymond James & Associates's largest Q1 2018 buy was Nutrien: 608,282 shares worth $28.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2018, an estimated $211M increase.
  • Raymond James & Associates's biggest Q1 2018 reduction was AbbVie, cutting an estimated $68.1M.
  • Raymond James & Associates fully exited Regal Entertainment Group in Q1 2018, selling an estimated $48.4M.
  • Raymond James & Associates's ten largest holdings make up 20% of its $55.7B portfolio in Q1 2018.
  • Raymond James & Associates opened 269 new positions and closed 227 in Q1 2018.
  • Raymond James & Associates's portfolio value rose 2.4% quarter-over-quarter to $55.7B.

Based on Raymond James & Associates's 13F filing for Q1 2018, filed 14 May 2018.